ReviewFrontiers in immunology2017
Toll-Like Receptor 3 Signal in Dendritic Cells Benefits Cancer Immunotherapy.
Misako Matsumoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
40 papers cite it
this papertrialcites it
ReviewFrontiers in immunology2017
Misako Matsumoto et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.